These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 150283)
1. Immunoelectronmicroscopic examination of early lesions in histamine induced immune complex vasculitis in man. Wolff HH; Maciejewski W; Scherer R; Braun-Falco O Br J Dermatol; 1978 Jul; 99(1):13-24. PubMed ID: 150283 [TBL] [Abstract][Full Text] [Related]
2. Demonstration of circulating and tissue-fixed immune complexes in cutaneous necrotizing vasculitis. Imamura S; Yanase K Acta Derm Venereol; 1980; 60(5):389-92. PubMed ID: 6162308 [TBL] [Abstract][Full Text] [Related]
3. Complement-mediated endothelial cell damage in immune complex vasculitis of the skin: ultrastructural localization of the membrane attack complex. Boom BW; Mommaas M; Daha MR; Vermeer BJ J Invest Dermatol; 1989 Aug; 93(2 Suppl):68S-72S. PubMed ID: 2666524 [TBL] [Abstract][Full Text] [Related]
4. Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angitis. Braverman IM; Yen A J Invest Dermatol; 1975 Feb; 64(2):105-12. PubMed ID: 123546 [TBL] [Abstract][Full Text] [Related]
5. Circulating and tissue-bound immune complexes in allergic vasculitis: relationship between immunoglobulin class and clinical features. Kauffmann RH; Herrmann WA; Meijer CJ; Daha MR; Vanes LA Clin Exp Immunol; 1980 Sep; 41(3):459-70. PubMed ID: 7438561 [TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the immunopathology of skin lesions and circulating immune complexes in leucocytoclastic vasculitis (Gougerot-Ruiter's disease) (author's transl)]. Gomes MA; Dambuyant C; Fernandez-Bussy R; Thivolet J Ann Dermatol Venereol; 1982; 109(1):35-41. PubMed ID: 7041772 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic correlation of 282 leukocytoclastic vasculitis cases in a tertiary hospital: a focus on direct immunofluorescence findings at the blood vessel wall. Takatu CM; Heringer APR; Aoki V; Valente NYS; de Faria Sanchez PC; de Carvalho JF; Criado PR Immunol Res; 2017 Feb; 65(1):395-401. PubMed ID: 27530606 [TBL] [Abstract][Full Text] [Related]
8. Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. Gower RG; Sams WM; Thorne EG; Kohler PF; Claman HN J Invest Dermatol; 1977 Nov; 69(5):477-84. PubMed ID: 908847 [TBL] [Abstract][Full Text] [Related]
9. Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase. Lipitsä T; Naukkarinen A; Laitala J; Harvima IT Arch Dermatol Res; 2016 Oct; 308(8):575-84. PubMed ID: 27465068 [TBL] [Abstract][Full Text] [Related]
10. Mesoglycan treatment restores defective fibrinolytic potential in cutaneous necrotizing venulitis. Lotti T; Celasco G; Tsampau D; Teofoli P; Benci M; Dahm M; Comacchi C; Ghersetich I; Matucci-Cerinic M Int J Dermatol; 1993 May; 32(5):368-71. PubMed ID: 8505166 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous vasculitis and immune complexes in severe bronchiectasis. Hilton AM; Hasleton PS; Bradlow A; Leahy BC; Cooper KM; Moore M Thorax; 1984 Mar; 39(3):185-91. PubMed ID: 6710426 [TBL] [Abstract][Full Text] [Related]